Rotop - Dmsa
Product Images NDC 71647-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rotop - Dmsa (NDC 71647-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rotop Pharmaka Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rotop Dmsa 01

FDA Label Image

Rotop Dmsa 02

Rotop Dmsa 02
This is a medication indicated for use in infants, children, and adults. It is meant for intravenous use and must be reconstituted and labeled before administration. The package contains 1.74 mg of powder for injection. Lot number and expiration date are not provided.*
FDA Label Image

Rotop Dmsa 03

Rotop Dmsa 03
ROTOP - DMSA 1.0 mg is a radiopharmaceutical preparation kit containing Succimer, which can be used in infants, children, and adults. Each kit contains 5 vials, and each vial contains 1.74 mg of powder to be used to make an injection solution. The active substance, Succimer, is present in each vial at a concentration of 1.0 mg. The excipients present in the preparation include stannous chloride dihydrate, ascorbic acid, sodium hydroxide, hydrochloric acid, and nitrogen. The solution is for intravenous use after reconstitution and labeling. It is recommended to store the original package in the fridge at a temperature range of 2 - 8 °C to protect it from light. The product should be kept out of the sight and reach of children. The product is a pharmacy-only medicine bearing the MA Number 3003663.00.00 and manufactured by ROTOP Pharmaka GmbH, located at Bautzner LandstraBe 400, 01328 Dresden, Germany.*
FDA Label Image

Rotop Dmsa 04

Rotop Dmsa 04
This is a product intended for intravenous use in infants, children, and adults. It comes in the form of a powder that needs to be reconstituted and labeled before use. The lot and expiration date are not available.*
FDA Label Image

Rotop Dmsa 05

Rotop Dmsa 05
ROTOP - DMSA 1.0 mg is a radiopharmaceutical preparation kit for use in infants, children and adults. Each of the 5 vials contains 1.74 mg powder for injection, comprising of an active substance of 1.0 mg succimer, and excipients such as stannous chloride dihydrate, ascorbic acid, sodium hydroxide, hydrochioric acid, and nitrogen. The reconstituted product is intended for intravenous use after labeling. It should be stored in the original package in a refrigerator at 2 - 8 °C, protected from light, and kept out of reach of children. This product is a pharmacy-only medicine and is manufactured by ROTOP Pharmaka GmbH in Germany.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.